Finance

Lists
688526:SHA
Wuhan Keqian Biology Co Ltd
CNÂ¥11.86
-1.00%
(-0.12) 1D
Oct 15, 2:47:47 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688526...
Open
CNÂ¥11.98
High
CNÂ¥12.01
Low
CNÂ¥11.82
Mkt. cap
5.66B
Avg. vol.
1.31M
Volume
1.15M
Dividend
5.40%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
17.56
52-wk high
CNÂ¥17.81
52-wk low
CNÂ¥11.65
EPS
CNÂ¥0.68
No. of employees
935
Open
CNÂ¥11.98
High
CNÂ¥12.01
Low
CNÂ¥11.82
Mkt. cap
5.66B
Avg. vol.
1.31M
Volume
1.15M
Dividend
5.40%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
17.56
52-wk high
CNÂ¥17.81
52-wk low
CNÂ¥11.65
EPS
CNÂ¥0.68
No. of employees
935
News stories
From web sources and news partners
About Wuhan Keqian Biology Co Ltd
CEO-
Employees935
FoundedJan 11, 2001
Headquarters-
SectorPharmaceutical industry
Websitekqbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
250.57M
211.88M
227.54M
146.29M
Cost of goods sold
81.77M
86.92M
81.91M
78.95M
Cost of revenue
81.77M
86.92M
81.91M
78.95M
Research and development expenses
26.38M
24.54M
25.10M
34.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.53M
35.58M
35.67M
34.00M
Operating expense
34.92M
89.78M
64.34M
68.80M
Total operating expenses
116.68M
176.70M
146.25M
147.75M
Operating income
133.89M
35.18M
81.28M
-1.46M
Other non operating income
-717.89K
2.18M
559.75K
-1.19M
EBT including unusual items
135.40M
92.57M
90.10M
38.63M
EBT excluding unusual items
143.50M
55.13M
94.15M
8.42M
Income tax expense
18.07M
12.23M
11.42M
2.60M
Effective tax rate
13.35%
13.21%
12.67%
6.73%
Other operating expenses
-9.53M
11.28M
-3.75M
4.42M
Net income
117.90M
80.93M
79.24M
36.49M
Net profit margin
47.05%
38.20%
34.82%
24.94%
Earnings per share
-
-
-
-
Interest and investment income
10.45M
18.66M
12.38M
10.54M
Interest expense
-122.12K
-
-72.17K
-69.97K
Net interest expenses
10.33M
18.66M
12.30M
10.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
160.94M
63.12M
109.22M
29.59M
Gain or loss from assets sale
-
6.90M
-
1.90M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps